HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS TRANSPLANTATION IN LYMPHOMATOUSPOLYPOSIS IN 2ND REMISSION - 3 CASE-REPORTS AND LITERATURE-REVIEW

Citation
Ra. Popescu et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS TRANSPLANTATION IN LYMPHOMATOUSPOLYPOSIS IN 2ND REMISSION - 3 CASE-REPORTS AND LITERATURE-REVIEW, Bone marrow transplantation, 22(1), 1998, pp. 103-106
Citations number
14
Categorie Soggetti
Hematology,Oncology,Immunology,Transplantation
Journal title
ISSN journal
02683369
Volume
22
Issue
1
Year of publication
1998
Pages
103 - 106
Database
ISI
SICI code
0268-3369(1998)22:1<103:HCAATI>2.0.ZU;2-#
Abstract
Lymphomatous polyposis is a rare primary gastrointestinal lymphoma. It morphologically and immunohistochemically resembles mantle cell lymph oma, with which it shares a disappointing response rate and duration f ollowing conventional anthracyclin-containing combination chemotherapy , with a short median survival and virtually no long-term survivors, W e report the use of high-dose chemotherapy with autologous stem cell t ransplantation in second partial remission in three patients with lymp homatous polyposis treated at the Royal Marsden Hospital. All patients achieved a complete response, and one patient remains well and diseas e-free 64 months following transplantation and 76 months after diagnos is.